Characteristics | No. (n=126) | Hazard ratio | 95% CI | P value | |
---|---|---|---|---|---|
Gender | Â | Â | Â | Â | Â |
 | Male | 84 |  |  |  |
 | Female | 42 | 1.14 | 0.61–2.13 | 0.685 |
Disease | Â | Â | Â | Â | Â |
 | Primary tumor only | 65 |  |  |  |
 | Local recurrence | 33 | 2.28 | 1.03–5.05 | 0.042 |
 | Synchronous Metastasis | 28 | 3.91 | 1.89–8.09 | 0.0002 |
Treatment mode | Â | Â | Â | Â | Â |
 | RT | 53 |  |  |  |
 | CRT | 73 | 0.97 | 0.52–1.81 | 0.92 |
Grade 3 toxicity | Â | Â | Â | Â | Â |
 | No | 82 |  |  |  |
 | Yes | 44 | 1.48 | 0.73–3.02 | 0.281 |
Continuous variables | Â | Â | Â | Â | |
 | Age | 126 | 1.13 | 1.07–1.20 | 0.00002 |
 | KPS Score | 126 | 0.99 | 0.95–1.02 | 0.558 |
 | ECOG Score | 126 | 1.42 | 0.93–2.17 | 0.103 |
 | Charlson Score | 126 | 1.21 | 1.09–1.36 | 0.001 |